Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Witt

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
Nature Communications|July 27, 2023
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomasRomain Sigaud, Thomas K Albert, Caroline Hess, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Cancer Cell|August 16, 2011
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymomaHendrik Witt, Stephen C Mack, Marina Ryzhova, et al.
Nature|May 7, 2025
Oncogene aberrations drive medulloblastoma progression, not initiationKonstantin Okonechnikov, Piyush Joshi, Verena Körber, et al.
Oncotarget|August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastomaJohannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Neuro-Oncology|April 19, 2023
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patientsEmily C Hardin, Simone Schmid, Alexander Sommerkamp, et al.
Cancer Cell|November 5, 2013
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasSebastian Bender, Yujie Tang, Anders M Lindroth, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2019
Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experienceElke Pfaff, Ahmed El Damaty, Gnana Prakash Balasubramanian, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
Nature Communications|July 27, 2023
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomasRomain Sigaud, Thomas K Albert, Caroline Hess, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Cancer Cell|August 16, 2011
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymomaHendrik Witt, Stephen C Mack, Marina Ryzhova, et al.
Nature|May 7, 2025
Oncogene aberrations drive medulloblastoma progression, not initiationKonstantin Okonechnikov, Piyush Joshi, Verena Körber, et al.
Oncotarget|August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastomaJohannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Neuro-Oncology|April 19, 2023
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patientsEmily C Hardin, Simone Schmid, Alexander Sommerkamp, et al.
Cancer Cell|November 5, 2013
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasSebastian Bender, Yujie Tang, Anders M Lindroth, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2019
Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experienceElke Pfaff, Ahmed El Damaty, Gnana Prakash Balasubramanian, et al.
Pageof 25